Low Molecular Seleno-Aminopolysaccharides Protect the Intestinal Mucosal Barrier of Rats under Weaning Stress

Zhengshun Wen, Ming Du, Zhen Tang, Tianyi Zhou, Zhongshan Zhang, Houhui Song, Xingwei Xiang, Xinyan HanInternational Journal of Molecular Sciences 2019 · DOI

TL;DR

This study introduces a novel compound, low molecular seleno-aminopolysaccharide (LSA), and demonstrates its potent protective effects on the intestinal barrier of rats experiencing weaning stress. LSA mitigates damage, enhances antioxidant defenses, and promotes the integrity of the intestinal lining by activating the Nrf2 signaling pathway.

What Problem Does This Paper Address?

Weaning is a critical and stressful period for young mammals, often leading to significant disruption of the intestinal mucosal barrier. This disruption can manifest as increased permeability, oxidative damage, and a compromised immune response, potentially impacting long-term health. Current strategies to mitigate weaning stress and its consequences are limited, creating a need for novel therapeutic or preventative agents. This paper addresses the challenge of protecting the delicate intestinal barrier during this vulnerable phase.

Methods

The researchers synthesized a novel compound, low molecular seleno-aminopolysaccharide (LSA), by combining sodium selenite with low molecular aminopolysaccharide. They then investigated its effects on weaned rats using a multi-pronged approach:

  • Histomorphology: Assessed intestinal villus height, crypt depth, and mucosal thickness using H&E staining and AB-PAS staining for goblet cells.
  • Biochemical Assays: Measured serum levels of diamine oxidase (DAO), D-lactic acid (D-LA), and lipopolysaccharide (LPS) as indicators of intestinal injury and permeability. Antioxidant status was evaluated by measuring serum and tissue levels of glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), catalase (CAT), and malondialdehyde (MDA).
  • Mucin Structure Analysis: Investigated the structure of intestinal mucin MUC2 using SDS-agarose gel electrophoresis and mass spectrometry to analyze glycan chains.
  • Gene Expression Analysis: Quantified the mRNA expression levels of antioxidant genes (GSH-Px, SOD, Nrf2, HO-1), glycosyltransferase genes (GalNT1, GalNT3, GalNT7), and the mucin gene (MUC2) in intestinal mucosa via RT-PCR.
  • Protein Expression Analysis: Examined the protein expression levels of the transcription factors Nrf2 and Keap1 in intestinal mucosa using Western blotting.

Datasets

Not discussed in the paper. The study utilized experimental animal models (weaning rats) and their biological samples (serum, intestinal tissue).

Key Insights and Ideas

  • LSA as a Multifaceted Protector: The study reveals LSA's ability to act on multiple fronts to protect the intestinal barrier, addressing structural integrity, permeability, oxidative stress, and mucin composition.
  • Nrf2 Pathway Activation is Key: A central finding is that LSA's protective effects are mediated, at least in part, by activating the Nrf2 signaling pathway. This pathway is crucial for cellular defense against oxidative stress.
  • MUC2 Glycosylation Matters: LSA's positive impact on the structure and glycosylation of MUC2, a critical component of the mucus layer, highlights the importance of this specific mucin in maintaining barrier function.
  • Synergistic Selenium and Polysaccharide Effects: The synthesis of LSA suggests a potential synergistic benefit from combining selenium with aminopolysaccharides, offering a more potent therapeutic agent than either component alone.

Key Results

  • Improved Intestinal Morphology: LSA significantly increased villus height and mucosal thickness, and the number of goblet cells, indicating enhanced structural integrity.
  • Reduced Intestinal Permeability: Serum levels of DAO, D-LA, and LPS were significantly reduced in LSA-treated rats, suggesting a strengthened intestinal barrier.
  • Enhanced Antioxidant Capacity: LSA treatment led to increased levels of antioxidant enzymes (GSH-Px, SOD, CAT) and decreased levels of MDA (a marker of oxidative damage) in both serum and intestinal tissue.
  • Restored MUC2 Structure: LSA increased the number and length of glycans chains and the abundance of acidic glycans in MUC2, alleviating weaning-induced changes.
  • Upregulated Key Genes: RT-PCR showed LSA significantly increased the expression of antioxidant genes (GSH-Px, SOD, Nrf2, HO-1), glycosyltransferase genes (GalNT1, GalNT3, GalNT7), and the MUC2 gene.
  • Activated Nrf2 Signaling: Western blot analysis confirmed that LSA activated the Nrf2 pathway by down-regulating Keap1 and up-regulating Nrf2 protein expression.

Limitations and Future Work

  • In Vivo Focus: While promising, the study was conducted in an animal model. Further research is needed to confirm these findings in human infants or other relevant species.
  • Mechanism Specificity: While Nrf2 activation is highlighted, other potential mechanisms of LSA's action may exist and warrant further investigation.
  • Long-Term Effects: The study focused on a 14-day trial. Long-term studies would be beneficial to assess the sustained protective effects of LSA.
  • Dosage Optimization: While a specific dose was used, further studies could explore optimal dosage ranges for LSA.

The authors suggest that LSA could be a valuable agent for the prevention and management of gastrointestinal disorders associated with weaning stress, particularly in infants. Future work could explore its therapeutic potential in clinical settings.

Summary updated

Abstract

Low molecular seleno-aminopolysaccharide (LSA) was synthesized with sodium selenite and low molecular aminopolysaccharide (LA), which is an organic selenium compound. This study is aimed to investigate the protective effect of LSA on the intestinal mucosal barrier in weaning stress rats by detecting the intestinal tissue morphology and function, mucosal thickness and permeability, the structure of MUC2, antioxidant index, the expression level of intracellular transcription factor NF-E2-related factor 2 (Nrf2), and its related factors. The results showed that LSA significantly increased the height of intestinal villi (<i>p</i> < 0.05) and increased the thickness of intestinal mucosa and the number of goblet cells, which indicated that LSA has a protective effect on the intestinal mucosal barrier that is damaged by weaning. Moreover, LSA significantly reduced the level of DAO, D-LA, and LPS compared with the weaning group (<i>p</i> < 0.05), which indicated that LSA reduced the intestinal damage and permeability of weaning rats. In addition, LSA could increase the number and length of glycans chains and the abundance of acid glycans structures in the MUC2 structure, which indicated that LSA alleviated the changes of intestinal mucus protein structure. LSA significantly increased the levels of GSH-Px, SOD, LDH, and CAT, while it decreased the level of MDA in serum and intestinal tissue, which suggested that LSA significantly enhanced the antioxidant capacity and reduced oxidative stress of weaning rats. RT-PCR results showed that LSA significantly increased the expression level of antioxidant genes (GSH-Px, SOD, Nrf2, HO-1), glycosyltransferase genes (GalNT1, GalNT3, GalNT7) and mucin gene (MUC2) in intestinal mucosa (<i>p</i> < 0.05). The results of western blot showed that the LSA activated the Nrf2 signaling pathway by down-regulating the expression of Keap1and up-regulating the expression of Nrf2, and protected the intestinal mucosa from oxidative stress. Overall, LSA could play a protective role in intestinal mucosal barrier of weaning rats by activating the Nrf2 pathway and alleviating the alnormal change of mucin MUC2.
BibTeX
@article{wen2019low,
  author = {Zhengshun Wen and Ming Du and Zhen Tang and Tianyi Zhou and Zhongshan Zhang and Houhui Song and Xingwei Xiang and Xinyan Han},
  title = {{Low Molecular Seleno-Aminopolysaccharides Protect the Intestinal Mucosal Barrier of Rats under Weaning Stress}},
  journal = {International Journal of Molecular Sciences},
  year = {2019},
  doi = {10.3390/ijms20225727},
}
Figure